Commentary: The next chapter in donor heart preservation: Modulation of preservation biology by targeted molecular therapies.
作者信息
Lei Ienglam, Tang Paul C
机构信息
Department of Cardiac Surgery, University of Michigan, Ann Arbor, Mich.
出版信息
JTCVS Tech. 2021 Jul 1;9:95-96. doi: 10.1016/j.xjtc.2021.06.037. eCollection 2021 Oct.
Abstract
摘要
相似文献
1
Commentary: The next chapter in donor heart preservation: Modulation of preservation biology by targeted molecular therapies.
JTCVS Tech. 2021 Jul 1;9:95-96. doi: 10.1016/j.xjtc.2021.06.037. eCollection 2021 Oct.
2
Graft preservation in heart transplantation: current approaches.
Front Cardiovasc Med. 2023 Aug 11;10:1253579. doi: 10.3389/fcvm.2023.1253579. eCollection 2023.
3
Supplementing preservation solution with mitochondria-targeted H S donor AP39 protects cardiac grafts from prolonged cold ischemia-reperfusion injury in heart transplantation.
Am J Transplant. 2019 Nov;19(11):3139-3148. doi: 10.1111/ajt.15539. Epub 2019 Sep 3.
4
Donor Heart Recovery and Preservation Modalities in 2024.
JACC Heart Fail. 2024 Mar;12(3):427-437. doi: 10.1016/j.jchf.2023.10.012. Epub 2023 Nov 29.
5
Utilization of Paragonix SherpaPak for human donor heart preservation.
Multimed Man Cardiothorac Surg. 2021 Jun 16;2021. doi: 10.1510/mmcts.2021.035.
6
Commentary: Keeping your cool: Donor heart preservation using the SherpaPak Cardiac Transport System.
J Thorac Cardiovasc Surg. 2020 Feb;159(2):e125-e126. doi: 10.1016/j.jtcvs.2019.06.077. Epub 2019 Jul 18.
7
Preservation of the donor heart: from basic science to clinical studies.
Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):510-9. doi: 10.1093/icvts/ivu432. Epub 2014 Dec 23.
8
Donor heart preservation in an empty beating state under mild hypothermia.
Ann Thorac Surg. 2010 May;89(5):1518-23. doi: 10.1016/j.athoracsur.2010.02.008.
9
[Donor heart preservation with University of Wisconsin solution and immunosuppressive therapy with drip-infusion of tacrolimus].
Kyobu Geka. 2013 Jan;66(1):37-41.
10
Donor Heart Preservation: Current Knowledge and the New Era of Machine Perfusion.
Int J Mol Sci. 2023 Nov 24;24(23):16693. doi: 10.3390/ijms242316693.
本文引用的文献
1
Improving circulatory death donor heart function: A novel approach.
JTCVS Tech. 2021 Jun 12;9:89-92. doi: 10.1016/j.xjtc.2021.06.018. eCollection 2021 Oct.
2
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950.
Pharmacol Rev. 2021 Jul;73(3):968-1000. doi: 10.1124/pharmrev.120.000171.
3
Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart.
Clin Transplant. 2020 Oct;34(10):e14044. doi: 10.1111/ctr.14044. Epub 2020 Aug 2.
4
The donor heart and organ perfusion technology.
J Thorac Dis. 2019 Apr;11(Suppl 6):S938-S945. doi: 10.21037/jtd.2019.02.59.
5
Hearts Donated After Circulatory Death and Reconditioned Using Normothermic Regional Perfusion Can Be Successfully Transplanted Following an Extended Period of Static Storage.
Circ Heart Fail. 2019 Apr;12(4):e005364. doi: 10.1161/CIRCHEARTFAILURE.118.005364.
6
Preservation of the donor heart: from basic science to clinical studies.
Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):510-9. doi: 10.1093/icvts/ivu432. Epub 2014 Dec 23.
7
Heart fields and cardiac morphogenesis.
Cold Spring Harb Perspect Med. 2014 Oct 1;4(10):a015750. doi: 10.1101/cshperspect.a015750.
8
Animal models of heart failure: a scientific statement from the American Heart Association.
Circ Res. 2012 Jun 22;111(1):131-50. doi: 10.1161/RES.0b013e3182582523. Epub 2012 May 17.
9
Organ preservation.
Annu Rev Med. 1995;46:235-47. doi: 10.1146/annurev.med.46.1.235.
10
Myocardial protection during surgical coronary reperfusion.
J Am Coll Cardiol. 1983 May;1(5):1235-46. doi: 10.1016/s0735-1097(83)80135-1.
Zotero 插件